Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2011 · 10-Q
Revenue$9.04B$9.04B+17.4% vs Q1 2010 Net Income$863.80M$863.80M−13.9% vs Q1 2010 EPS Diluted$0.55$0.55−14.1% vs Q1 2010 Gross Profit$5,181,900,000+18.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$2,011,146,000+32.1% Free Cash Flowderived$1,619,333,000+26.7% Margins · derivedGross margin57.3%+0.6 pt vs Q1 2010
Operating margin14.4%−4.7 pt vs Q1 2010
Net margin9.6%−3.5 pt vs Q1 2010
ended Mar 31, 2011 · filed May 6, 2011 · 36 d after period end